- Home
- BYFC vs NSPR Comparison
BYFC vs NSPR Comparison
Compare BYFC & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- NSPR
- Stock Information
- Founded
- BYFC 1946
- NSPR 2005
- Country
- BYFC United States
- NSPR United States
- Employees
- BYFC N/A
- NSPR N/A
- Industry
- BYFC Savings Institutions
- NSPR Medical/Dental Instruments
- Sector
- BYFC Finance
- NSPR Health Care
- Exchange
- BYFC Nasdaq
- NSPR Nasdaq
- Market Cap
- BYFC 70.3M
- NSPR 74.8M
- IPO Year
- BYFC 1996
- NSPR N/A
- Fundamental
- Price
- BYFC $7.31
- NSPR $2.40
- Analyst Decision
- BYFC
- NSPR Strong Buy
- Analyst Count
- BYFC 0
- NSPR 2
- Target Price
- BYFC N/A
- NSPR $4.50
- AVG Volume (30 Days)
- BYFC 5.9K
- NSPR 112.3K
- Earning Date
- BYFC 07-31-2025
- NSPR 08-05-2025
- Dividend Yield
- BYFC N/A
- NSPR N/A
- EPS Growth
- BYFC N/A
- NSPR N/A
- EPS
- BYFC N/A
- NSPR N/A
- Revenue
- BYFC $33,412,000.00
- NSPR $7,066,000.00
- Revenue This Year
- BYFC N/A
- NSPR $4.85
- Revenue Next Year
- BYFC N/A
- NSPR $113.47
- P/E Ratio
- BYFC N/A
- NSPR N/A
- Revenue Growth
- BYFC N/A
- NSPR 7.60
- 52 Week Low
- BYFC $5.71
- NSPR $1.99
- 52 Week High
- BYFC $9.46
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- BYFC 37.34
- NSPR 46.33
- Support Level
- BYFC $7.26
- NSPR $2.36
- Resistance Level
- BYFC $8.20
- NSPR $2.52
- Average True Range (ATR)
- BYFC 0.10
- NSPR 0.12
- MACD
- BYFC -0.10
- NSPR -0.02
- Stochastic Oscillator
- BYFC 5.32
- NSPR 20.00
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.